Candriam SCA’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Hold
0
784
2020
Q2
Sell
-82,200
Closed -$703K 850
2020
Q1
$703K Hold
82,200
0.01% 686
2019
Q4
$719K Sell
82,200
-141,000
-63% -$1.17M 0.01% 703
2019
Q3
$2.4M Hold
223,200
0.03% 457
2019
Q2
$2.82M Buy
223,200
+208,586
+1,427% +$4.8M 0.04% 441
2019
Q1
$567K Sell
14,614
-331,123
-96% -$10.1M 0.01% 698
2018
Q4
$7.04M Buy
345,737
+29,537
+9% +$886K 0.11% 219
2018
Q3
$14.5M Buy
316,200
+211,200
+201% +$10.2M 0.19% 124
2018
Q2
$6.21M Buy
105,000
+37,000
+54% +$2.14M 0.1% 258
2018
Q1
$4.63M Buy
68,000
+27,000
+66% +$2.02M 0.08% 294
2017
Q4
$4.05M Sell
41,000
-16,500
-29% -$1.85M 0.07% 310
2017
Q3
$6.89M Buy
57,500
+8,500
+17% +$791K 0.12% 212
2017
Q2
$4.28M Sell
49,000
-105,500
-68% -$5.9M 0.08% 293
2017
Q1
$5.75M Buy
154,500
+45,000
+41% +$1.64M 0.11% 221
2016
Q4
$3.36M Buy
109,500
+41,500
+61% +$1.79M 0.08% 278
2016
Q3
$4.56M Sell
68,000
-24,000
-26% -$1.21M 0.11% 208
2016
Q2
$2.74M Sell
92,000
-17,000
-16% -$531K 0.07% 264
2016
Q1
$3.18M Buy
109,000
+24,700
+29% +$1.12M 0.08% 258
2015
Q4
$6.61M Buy
84,300
+24,000
+40% +$1.88M 0.18% 141
2015
Q3
$4.54M Buy
60,300
+31,300
+108% +$2.96M 0.11% 218
2015
Q2
$3.39M Buy
29,000
+12,000
+71% +$2.17M 0.07% 292
2015
Q1
$4.01M Buy
17,000
+3,000
+21% +$641K 0.08% 288
2014
Q4
$2.65M Buy
+14,000
New +$3.11M 0.06% 323

Other funds holding PBYI